{"entity":{"type":"insider","cik":"0001492647","url":"/insider/0001492647","json_url":"/insider/0001492647.json","name":"Almenoff June Sherie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":15,"first":"2011-09-13","last":"2025-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Almenoff June Sherie","source":"filing","n_filings":15,"first_seen":"2011-09-13","last_seen":"2025-11-20"}],"transactions":[{"id":9289858,"accession":"0001492647-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001492647-25-000004","line_url":"/filing/0001492647-25-000004#line-2","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"TENAX THERAPEUTICS, INC.","issuer_ticker":"TENX","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":7.5157,"price_display":"7.52","price_state":"stated","total_value":14279.83,"total_display":"14,279.83","total_whole":"14,280","shares_owned_after":1993.0,"shares_owned_after_display":"1,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-20","scope":"insider"},{"id":4893017,"accession":"0001492647-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001492647-25-000003","line_url":"/filing/0001492647-25-000003#line-2","is_derivative":false,"issuer_cik":"0000034956","issuer_name":"TENAX THERAPEUTICS, INC.","issuer_ticker":"TENX","issuer_name_source":null,"issuer_url":"/issuer/0000034956","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":7.5157,"price_display":"7.52","price_state":"stated","total_value":14279.83,"total_display":"14,279.83","total_whole":"14,280","shares_owned_after":1993.0,"shares_owned_after_display":"1,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":9289859,"accession":"0001492647-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492647-25-000004","line_url":"/filing/0001492647-25-000004#line-1","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"TENAX THERAPEUTICS, INC.","issuer_ticker":"TENX","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":93.0,"shares_display":"93","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":664.95,"total_display":"664.95","total_whole":"665","shares_owned_after":93.0,"shares_owned_after_display":"93","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-20","scope":"insider"},{"id":4893013,"accession":"0001492647-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492647-25-000003","line_url":"/filing/0001492647-25-000003#line-1","is_derivative":false,"issuer_cik":"0000034956","issuer_name":"TENAX THERAPEUTICS, INC.","issuer_ticker":"TENX","issuer_name_source":null,"issuer_url":"/issuer/0000034956","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":93.0,"shares_display":"93","price_per_share":7.15,"price_display":"7.15","price_state":"stated","total_value":664.95,"total_display":"664.95","total_whole":"665","shares_owned_after":93.0,"shares_owned_after_display":"93","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":3185851,"accession":"0001578563-24-000441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001578563-24-000441","line_url":"/filing/0001578563-24-000441#line-2","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":6500.0,"total_display":"6,500.00","total_whole":"6,500","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-14","scope":"insider"},{"id":3185849,"accession":"0001578563-24-000441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-24-000441","line_url":"/filing/0001578563-24-000441#line-1","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"Avalo Therapeutics, Inc.","issuer_ticker":"AVTX","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":12.499,"price_display":"12.50","price_state":"stated","total_value":6249.5,"total_display":"6,249.50","total_whole":"6,250","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-14","scope":"insider"},{"id":7785967,"accession":"0001144204-19-000986","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-19-000986","line_url":"/filing/0001144204-19-000986#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1475.0,"shares_display":"1,475","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":5000.25,"total_display":"5,000.25","total_whole":"5,000","shares_owned_after":7175.0,"shares_owned_after_display":"7,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-08","scope":"insider"},{"id":6704639,"accession":"0001551986-18-000017","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001551986-18-000017","line_url":"/filing/0001551986-18-000017","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (COO and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (COO and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":4.94795,"price_display":"4.95","price_state":"stated","total_value":1979.18,"total_display":"1,979.18","total_whole":"1,979","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-27","filed_date":"2018-08-28","scope":"insider","n_lines":3},{"id":6704629,"accession":"0001551986-18-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001551986-18-000017","line_url":"/filing/0001551986-18-000017","is_derivative":false,"issuer_cik":"0001492647","issuer_name":"INNOVATE BIOPHARMACEUTICALS, INC.","issuer_ticker":"INNT","issuer_name_source":null,"issuer_url":"/issuer/0001492647","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (COO and Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (COO and Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO and Chief Medical Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.906,"price_display":"4.91","price_state":"stated","total_value":4906.0,"total_display":"4,906.00","total_whole":"4,906","shares_owned_after":1400.0,"shares_owned_after_display":"1,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-24","filed_date":"2018-08-28","scope":"insider","n_lines":3},{"id":9236956,"accession":"0001144204-18-015760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-015760","line_url":"/filing/0001144204-18-015760#line-1","is_derivative":false,"issuer_cik":"0001137883","issuer_name":"BRAINSTORM CELL THERAPEUTICS INC.","issuer_ticker":"BCLI","issuer_name_source":null,"issuer_url":"/issuer/0001137883","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5700.0,"shares_display":"5,700","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":19950.0,"total_display":"19,950.00","total_whole":"19,950","shares_owned_after":5700.0,"shares_owned_after_display":"5,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-20","scope":"insider"},{"id":8922772,"accession":"0001387131-15-000429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-000429","line_url":"/filing/0001387131-15-000429#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":40500.0,"total_display":"40,500.00","total_whole":"40,500","shares_owned_after":16900.0,"shares_owned_after_display":"16,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-06","filed_date":"2015-02-10","scope":"insider"},{"id":6800309,"accession":"0001387131-14-003195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-14-003195","line_url":"/filing/0001387131-14-003195#line-2","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":9660.0,"total_display":"9,660.00","total_whole":"9,660","shares_owned_after":127566.0,"shares_owned_after_display":"127,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-03","filed_date":"2014-09-04","scope":"insider"},{"id":6800307,"accession":"0001387131-14-003195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-003195","line_url":"/filing/0001387131-14-003195#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.12,"price_display":"8.12","price_state":"stated","total_value":8120.0,"total_display":"8,120.00","total_whole":"8,120","shares_owned_after":126366.0,"shares_owned_after_display":"126,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6685687,"accession":"0001387131-14-002346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-002346","line_url":"/filing/0001387131-14-002346#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3200.0,"shares_display":"3,200","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":26688.0,"total_display":"26,688.00","total_whole":"26,688","shares_owned_after":125366.0,"shares_owned_after_display":"125,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-26","filed_date":"2014-06-30","scope":"insider"},{"id":6445366,"accession":"0001387131-14-001338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-001338","line_url":"/filing/0001387131-14-001338#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":56375.0,"total_display":"56,375.00","total_whole":"56,375","shares_owned_after":122166.0,"shares_owned_after_display":"122,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-08","filed_date":"2014-04-09","scope":"insider"},{"id":6712789,"accession":"0001437749-14-001663","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-14-001663","line_url":"/filing/0001437749-14-001663","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115113.0,"shares_display":"115,113","price_per_share":115.28863377724497,"price_display":"115.29","price_state":"stated","total_value":13271220.5,"total_display":"13,271,220.50","total_whole":"13,271,221","shares_owned_after":46318.0,"shares_owned_after_display":"46,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-06","scope":"insider","n_lines":2},{"id":2152269,"accession":"0001181431-12-046074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-12-046074","line_url":"/filing/0001181431-12-046074#line-2","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":950.0,"shares_display":"950","price_per_share":18.68,"price_display":"18.68","price_state":"stated","total_value":17746.0,"total_display":"17,746.00","total_whole":"17,746","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-15","filed_date":"2012-08-16","scope":"insider"},{"id":2152265,"accession":"0001181431-12-046074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-046074","line_url":"/filing/0001181431-12-046074#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":18.55,"price_display":"18.55","price_state":"stated","total_value":927.5,"total_display":"927.50","total_whole":"928","shares_owned_after":6050.0,"shares_owned_after_display":"6,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-14","filed_date":"2012-08-16","scope":"insider"},{"id":3414669,"accession":"0001181431-12-031130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-031130","line_url":"/filing/0001181431-12-031130#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":14.8,"price_display":"14.80","price_state":"stated","total_value":29600.0,"total_display":"29,600.00","total_whole":"29,600","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-17","filed_date":"2012-05-18","scope":"insider"},{"id":2191460,"accession":"0001181431-12-012638","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-012638","line_url":"/filing/0001181431-12-012638#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":54630.0,"total_display":"54,630.00","total_whole":"54,630","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-24","filed_date":"2012-02-28","scope":"insider"},{"id":9080208,"accession":"0001181431-11-048952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-048952","line_url":"/filing/0001181431-11-048952#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001492647","owner_name":"Almenoff June Sherie","owner_display_name":"Almenoff June Sherie","owner_url":"/insider/0001492647","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":14950.0,"total_display":"14,950.00","total_whole":"14,950","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-09","filed_date":"2011-09-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":24,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000034956","name":"TENAX THERAPEUTICS, INC.","url":"/issuer/0000034956","role":"Director","n_filings":2,"first_seen":"2025-11-19","last_seen":"2025-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Avalo Therapeutics, Inc.","url":"/issuer/0001534120","role":"Director","n_filings":1,"first_seen":"2024-11-14","last_seen":"2024-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001137883","name":"BRAINSTORM CELL THERAPEUTICS INC.","url":"/issuer/0001137883","role":"Director","n_filings":2,"first_seen":"2018-03-20","last_seen":"2019-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001551986","name":"INNOVATE BIOPHARMACEUTICALS, INC.","url":"/issuer/0001551986","role":"Officer (COO and Chief Medical Officer)","n_filings":1,"first_seen":"2018-08-28","last_seen":"2018-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"Ohr Pharmaceutical Inc","url":"/issuer/0001173281","role":"Director","n_filings":4,"first_seen":"2014-04-09","last_seen":"2015-02-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001484478","name":"Furiex Pharmaceuticals, Inc.","url":"/issuer/0001484478","role":"Director, Officer (President)","n_filings":5,"first_seen":"2011-09-13","last_seen":"2014-02-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001492647","retrieved_at":"2026-08-24T03:03:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}